Cite

HARVARD Citation

    Philpott, J. et al. (2017). Efficacy of Vedolizumab in Patients with Antibiotic and Anti-tumor Necrosis Alpha Refractory Pouchitis. Inflammatory bowel diseases. 23 (1), pp. E5-E6. [Online]. 
  
Back to record